U.S. Markets closed

Inpixon (INPX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.0700+0.0200 (+1.90%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.0500
Open1.0400
Bid1.0500 x 1800
Ask1.0600 x 1800
Day's Range1.0300 - 1.0800
52 Week Range0.9210 - 29.2500
Volume2,948,540
Avg. Volume2,604,819
Market Cap53.691M
Beta (5Y Monthly)2.20
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Inpixon Enhances Enterprise-Class and Social Distancing Features with New Inpixon Mapping Release
    PR Newswire

    Inpixon Enhances Enterprise-Class and Social Distancing Features with New Inpixon Mapping Release

    Inpixon (Nasdaq: INPX), the Indoor Intelligence™ company, today announced the release of its latest indoor mapping platform, Inpixon Mapping 4.14. This release introduces a new customer administration tool, SDK-based dynamic wayfinding, additional tools for developers, and more.

  • Inpixon Announces Pricing of $10.0 Million Registered Direct Offering Priced At-The-Market
    PR Newswire

    Inpixon Announces Pricing of $10.0 Million Registered Direct Offering Priced At-The-Market

    Inpixon (Nasdaq: INPX), the Indoor Intelligence™ company, today announced that it has entered into a securities purchase agreement with an accredited institutional investor to purchase 8,000,000 shares of common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to an aggregate of 8,000,000 shares of common stock at a purchase price of $1.25 per share (or $1.249 per prefunded warrant) and accompanying warrant in a registered direct offering with a single institutional investor priced at-the-market under Nasdaq rules. The warrants have an exercise price of $1.25 per share, are exercisable immediately, and will expire five years following the date of issuance.

  • Inpixon Mapping Selected by Leading Pharmaceutical Corporation to Facilitate Tracking of COVID-19 Vaccine-Related Assets
    PR Newswire

    Inpixon Mapping Selected by Leading Pharmaceutical Corporation to Facilitate Tracking of COVID-19 Vaccine-Related Assets

    Inpixon (Nasdaq: INPX), the Indoor Intelligence™ company, today announced that Inpixon Mapping has been selected by one of the world's premier pharmaceutical companies to provide the visualization required for tracking its critical COVID-19 vaccine-related assets. Inpixon Mapping is currently contracted for deployment in multiple facilities utilized by this company, which specializes in the development of medicines and vaccines across a wide range of disciplines, and multiple additional locations are anticipated to be added over the coming weeks and months.